| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.15 | 3e-06 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.17 | 2e-05 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.13 | 9e-05 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0004 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0005 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0006 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0008 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0009 |